Protective Role of Magnesium Isoglycyrrhizinate in Non-Alcoholic Fatty Liver Disease and the Associated Molecular Mechanisms

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.2016.2603
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease

Children
2017English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Insulin Resistance in Non-Diabetic Patients With Non-Alcoholic Fatty Liver Disease: Sites and Mechanisms

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

Differences in the Genetic Backgrounds of Patients With Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease

JGH Open
HepatologyGastroenterology
2018English

Headway and Hurdles in Non-Alcoholic Fatty Liver Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2020English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

The Role of Dietary Sugars and De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease

Nutrients
NutritionFood ScienceDietetics
2014English

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy